CD177 and melanoma: Furthermore, our method relies on the production of melanin within melanoma cells, rather than the expression of cell surface receptors, and therefore offers an independent noninvasive modality that can complement other methods, such as ex vivo CTC detection assays that target cell surface receptors.28